[1]
2025. A Novel Benzenesulfonylurea-Substituted Pyridazinone Derivative with Antidiabetic Effect as the Peroxisome Proliferator-activated Receptor (PPAR-γ) Agonist. Jurnal Kimia Valensi. 11, 1 (May 2025), 18–29. DOI:https://doi.org/10.15408/jkv.v11i1.42187.